Cleared Traditional

JLK-AILink (K250348) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K250348 · JLK, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2025
Decision
19d
Days
Class 2
Risk

K250348 is an FDA 510(k) clearance for the JLK-AILink. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by JLK, Inc. (Seoul, KR). The FDA issued a Cleared decision on February 25, 2025 after a review of 19 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all JLK, Inc. devices

Submission Details

510(k) Number K250348 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2025
Decision Date February 25, 2025
Days to Decision 19 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
88d faster than avg
Panel avg: 107d · This submission: 19d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Third Party Review Group, LLC
Dave Yungvirt

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 787
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K250348.
SERV MEDICAL CDSS
K241975 · Serv Medical Pte., Ltd. · Mar 2025
PLANET Onco Dose (3.2)
K241765 · Dosisoft SA · Mar 2025
aiCockpit AI Viewer
K241546 · Fovia, Inc. · Feb 2025
QuickRad
K242838 · Aikenist Technologies Pvt, Ltd. · Feb 2025
CaRi-Plaque
K242240 · Caristo Diagnostics , Ltd. · Feb 2025
AspenView
K241425 · Aspen Imaging Healthcare, Inc. · Feb 2025